Which services do we offer:

• Biocides scoping assessments

• Turkey representative appointment (licence holder)

• Active substance approval preparation and submission

• Product authorisation preparation and submission

• Claim Substantiation

• Efficacy & Endpoint testing

• Product portfolio audits

• Stakeholder communication, BPR consultancy and regulatory monitoring

Hot Topics

Major amendments were made to the Turkey BPR at the start of 2022. Key among these changes is the requirement for companies to submit either a dossier or a letter of access for the active substance used inside their biocidal product, as part of the product licensing procedure (product authorisation). Previously, it was sufficient to demonstrate only that the active substance was either approved for use in the EU or included in the EU Review Programme. This change is part of a concerted effort in Turkey to build up a national database for active substances.

The Turkish Ministry of Health has overall responsibility for evaluating and approving active substances/biocidal products. Work is ongoing to bring this system online, with the portal expected to become active later this year.